Tsunami DRG High Frequency Stimulation Study
- Conditions
- Chronic Back PainChronic Back and Leg Pain
- Interventions
- Device: Spinal Cord Stimulator HFDevice: Spinal Cord Stimulator Sham
- Registration Number
- NCT03312010
- Lead Sponsor
- Curonix LLC
- Brief Summary
Prospective, double blinded, randomized, clinical study investigating the effects of high frequency SCS over exiting nerve roots at T9 for the treatment of chronic back or back and leg pain.
- Detailed Description
All subjects will have two permanent stimulators placed over the exiting nerve roots at T9 at the implant visit. The stimulators can easily be removed for non-responders. High frequency stimulation is typically programmed below sensory threshold. This type of stimulation lends itself to a placebo-controlled trial. For this study subjects will be randomized 1:1 at enrollment into a high frequency or sham group. Neither the subjects nor experimenters will be made aware of their randomization assignment for at least the first month of the trial. Subjects belonging to both groups will be unblinded to their assignment at the 1-month or a later visit (including unscheduled visit) if they have a VAS \> 30 mms. Subjects belonging to the sham group will be reprogrammed with HF stimulation at this point. Subjects belonging to the HF stimulation group will keep stimulating with HF. Subjects reporting a VAS \< 30 mms will continue to be blinded.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 38
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description High Frequency Spinal Cord Stimulator HF Subjects receiving high frequency pulse rate treatment over T9 exiting nerve roots. Subjects and assessors blinded Randomization. Sham Spinal Cord Stimulator Sham Subjects receiving Sham (non-active) treatment over T9 exiting nerve roots. Subjects and assessors blinded to randomization. Subjects and assessors to be unblinded if pain scores are 30 mms or higher with VAS after 1-month follow-up. Upon this moment subjects to receive active stimulation
- Primary Outcome Measures
Name Time Method Responder rate 1 month post-implant a \> 50% reduction in back pain as measured by VAS with the Freedom SCS system in the HF (test) group as opposed to sham and conventional medical management
- Secondary Outcome Measures
Name Time Method VAS leg pain 1, 3, 6, 9, 12 and 36 months Percentage change from baseline in VAS for leg pain
VAS back pain 1, 3, 6, 9, 12 and 36 months Percentage change from baseline in VAS for back pain
ODI 1, 3, 6, 9, 12 and 36 months Change from baseline in functionality using the ODI score
Trial Locations
- Locations (2)
GZA Sint-Augustinus
🇧🇪Wilrijk, Antwerpen, Belgium
AZ Delta
🇧🇪Roeselare, Belgium